STOCK TITAN

Prime Medicine, Inc. (PRME) Total Assets by Year

PRME

Prime Medicine, Inc. closed fiscal year 2025 with $342.7M in total assets, $221.9M in total liabilities and $120.9M in shareholder equity. This represents an increase of 15.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Prime Medicine, Inc. has filed alongside them.

FY2025 annual
Total Assets $342.7M
Total Liabilities $221.9M
Total Equity $120.9M
YoY +15.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PRME Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Total Assets$342.7M+15.2%$297.5M+53.5%$193.9M-46.2%$360.3M+19.4%$301.9MN/A
Total Liabilities$221.9M+53.7%$144.4M+137.5%$60.8M+38.0%$44.0M-90.4%$458.1MN/A
Total Equity$120.9M-21.1%$153.1M+15.1%$133.1M-57.9%$316.3M+302.4%-$156.2M-6782.6%$2.3M

PRME Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Total Assets$249.0M-10.7%$294.7M-10.2%$342.7M+15.2%$385.0M+15.7%$279.0M+7.4%$328.2M+5.4%$297.5M+53.5%$332.8M+39.2%$259.7M-7.5%$311.4M-1.8%$193.9M-46.2%$239.1M+11.1%
Total Liabilities$209.2M-4.1%$218.0M-1.5%$221.9M+53.7%$223.2M+55.8%$218.1M+245.6%$221.2M+227.2%$144.4M+137.5%$143.3M+217.1%$63.1M+54.8%$67.6M+77.3%$60.8M+38.0%$45.2M-89.7%
Total Equity$39.8M-34.6%$76.7M-28.3%$120.9M-21.1%$161.8M-14.6%$60.9M-69.0%$106.9M-56.1%$153.1M+15.1%$189.5M-2.3%$196.6M-18.1%$243.8M-12.6%$133.1M-57.9%$194.0M+186.9%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Prime Medicine, Inc. financials

Frequently Asked Questions

What was Prime Medicine, Inc.'s total assets in fiscal year 2025?

Prime Medicine, Inc. closed fiscal year 2025 with $342.7M in total assets, $221.9M in total liabilities and $120.9M in shareholder equity.

How fast is Prime Medicine, Inc.'s total assets growing?

Prime Medicine, Inc. (PRME) total assets rose by 15.2% year over year, from $297.5M to $342.7M in fiscal year 2025.

What was Prime Medicine, Inc.'s total assets in the most recent quarter?

Prime Medicine, Inc. (PRME) reported $249.0M in total assets in Q2 2026. This represents a decrease of 10.7% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Prime Medicine, Inc. (PRME) reported on that line in every period on record.